Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
- DOI
- 10.1016/j.cgh.2025.06.041
- Published
- 2026 Mar
- Container
- Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cgh.2025.06.041,
title = {Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.},
author = {Ahuja D and Yeh KH and Patel SB and Lee HH and Goodwin SW and Solitano V and Ma C and Ananthakrishnan AN and Singh N and Jairath V and Xu R and Singh S},
year = {2026},
journal = {Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association},
doi = {10.1016/j.cgh.2025.06.041},
url = {https://doi.org/10.1016/j.cgh.2025.06.041}
}RIS
TY - JOUR TI - Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases. AU - Ahuja D AU - Yeh KH AU - Patel SB AU - Lee HH AU - Goodwin SW AU - Solitano V AU - Ma C AU - Ananthakrishnan AN AU - Singh N AU - Jairath V AU - Xu R AU - Singh S PY - 2026 JO - Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association DO - 10.1016/j.cgh.2025.06.041 UR - https://doi.org/10.1016/j.cgh.2025.06.041 ER -
APA
D, A., KH, Y., SB, P., HH, L., SW, G., V, S., C, M., AN, A., N, S., V, J., R, X., & S, S. (2026). Comparative Safety of Janus Kinase Inhibitors vs Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. https://doi.org/10.1016/j.cgh.2025.06.041
Source records
- pubmed · retrieved 2026-09-27T15:56:16.474Z
- europe-pmc · retrieved 2026-09-27T15:56:16.477Z